NCT00238303 2014-05-23Vorinostat in Treating Patients With Progressive or Recurrent Glioblastoma MultiformeNational Cancer Institute (NCI)Phase 2 Completed103 enrolled 10 charts
NCT00641706 2014-05-14Vorinostat and Bortezomib in Treating Patients With Progressive, Recurrent Glioblastoma MultiformeNational Cancer Institute (NCI)Phase 2 Completed44 enrolled 9 charts